UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000010996
Receipt No. R000012797
Official scientific title of the study Nasopharyngeal Colonization, Distribution of Serotypes, and Antimicrobial Drug Susceptibility among Streptococcus pneumoniae / Haemophilus influenzae before and after Introducing of 7-valent Pneumococcal Conjugate Vaccine and H.influenzae type b vaccine in Sado, Japan -SADO Birth Cohort study-
Date of disclosure of the study information 2013/06/19
Last modified on 2017/07/03 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Nasopharyngeal Colonization, Distribution of Serotypes, and Antimicrobial Drug Susceptibility among Streptococcus pneumoniae / Haemophilus influenzae before and after Introducing of 7-valent Pneumococcal Conjugate Vaccine and H.influenzae type b vaccine in Sado, Japan -SADO Birth Cohort study-
Title of the study (Brief title) Nasopharyngeal Colonization, Distribution of Serotypes, and Antimicrobial Drug Susceptibility among Streptococcus pneumoniae / Haemophilus influenzae before and after Introducing of PCV7 and Hib vaccine in Sado, Japan -SADO Birth Cohort study-
Region
Japan

Condition
Condition Nasopharyngeal carriage
Classification by specialty
Pediatrics Oto-rhino-laryngology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the impact of PCV7 and Hib vaccine in nasopharyngeal carriage of S. pneumoniae and H. influenza. and to evaluate the relation between nasopharyngeal carriage on before and after PCV7 and serotype-specific immune reaction.
Basic objectives2 Others
Basic objectives -Others Colonization rate of S. pneumoniae and H. influenzae at 1-, 4-, 7-, 10-, 18-, 36-month of age.
2. Capsular serotypes of S. pneumoniae and H. influenzae at 1-, 4-, 7-, 10-, 18-, 36-month of age.
Trial characteristics_1
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes 1. Colonization rate of S. pneumoniae and H. influenzae at 1-, 4-, 7-, 10-, 18-, 36-month of age.
2. Capsular serotypes of S. pneumoniae and H. influenzae at 1-, 4-, 7-, 10-, 18-, 36-month of age.
Key secondary outcomes 1. Minimum inhibitory concentration (MIC) of S. pneumoniae and H. influenzae at 1-, 4-, 7-, 10-, 18-, 36-month of age.
2. Antimicrobial resistance genes of S. pneumoniae and H. influenzae at 1-, 4-, 7-, 10-, 18-, 36-month of age.
3. Serum antibody titer of infant aged a month carried pneumococcus in pre-and post- PCV7 vaccination

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Vaccine
Interventions/Control_1 7-valent Pneumococcal Conjugate Vaccine and H.influenzae type b vaccine
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
1 months-old <=
Age-upper limit
36 months-old >=
Gender Male and Female
Key inclusion criteria 1. Newborns born in Sado Island from July 1, 2012 to June 30, 2013.
2. Their guardians could understand the summary of the study.
3. Their guardians gave written informed consent before conducting this study.
Key exclusion criteria 1. Newborns had plan to move to other areas within 3 years
2. Newborns had congenital malformation.
3. For other reasons, newborns determined to be inappropriate for study entry by investigator.
Target sample size 350

Research contact person
Name of lead principal investigator Muneki Hotomi
Organization Wakayama Medical University
Division name Otolaryngology-Head and Neck Surgery
Address 811-1 Kimiidera Wakayama-shi, Wakayama, Japan.
TEL 073-441-0751
Email mhotomi@wakayama-med.ac.jp

Public contact
Name of contact person Muneki Hotomi
Organization Wakayama Medical University
Division name Otolaryngology-Head and Neck Surgery
Address 811-1 Kimiidera Wakayama-shi, Wakayama, Japan.
TEL 073-441-0751
Homepage URL
Email mhotomi@wakayama-med.ac.jp

Sponsor
Institute Otolaryngology-Head and Neck Surgery, Wakayama Medical University
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor Niigata welfare Federation of Agricultural Cooperative Associations, the Federation of Agricultural Cooperative Unions Sado general hospital
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 和歌山県立医科大学(和歌山県)

Other administrative information
Date of disclosure of the study information
2013 Year 06 Month 19 Day

Progress
Recruitment status Completed
Date of protocol fixation
2011 Year 03 Month 31 Day
Anticipated trial start date
2011 Year 07 Month 01 Day
Last follow-up date
2016 Year 06 Month 30 Day
Date of closure to data entry
2016 Year 11 Month 30 Day
Date trial data considered complete
2016 Year 12 Month 31 Day
Date analysis concluded
2017 Year 06 Month 30 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2013 Year 06 Month 18 Day
Last modified on
2017 Year 07 Month 03 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012797